DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Delos Advisors, Inc.
Delos Advisors, Inc.
Institutional venture firm · probableCambridge, MAdeloscapital.comSEC venture capital fund adviseremerging manager
Delos Capital invests in life science, biotech, and medtech companies transforming bold ideas into medical breakthroughs.
venture manager with no reported fund assets yet (scale unknown)
Importance
11
low
Active deployment
30
moderate
Emerging
81
high
Completeness
50
elevated
Freshness
100
high
Research priority
31
moderate
Identity and regulatory footprint
- Headquarters
- Cambridge, MAadviserinfo.sec.gov
- Office address
- 201 BROADWAY, SUITE 330, Cambridge, MA, 02139adviserinfo.sec.gov
- Business phone
- 617-634-3450adviserinfo.sec.gov
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Feb 27, 2026
- Private funds reported
- 0 (0 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- unknownadviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Delos Capital Advisors LLC (Shareholder Of Delos Advisors, Inc.), E
- business phone
- 617-634-3450adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
11 observed deals
Stated (the firm’s website)
- Sectors
- biotech
- Stages
- not stated or not yet read
- Geography
- global
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 91%Biotechnology 9%
lead rate n/afollow-on rate n/anew logos, 12 months 11
Funds and vehicles
0 reported
No vehicle on record yet. A fund arrives from Form ADV Schedule D 7.B.(1) or a Form D filing.
Investment team
14 current, 0 departed
Yang Cheng
AssociateAssociate
Henry Lin Chen
Founder or executivePresident Of Delos Advisors, Inc. · since Nov 1, 2023
Henry Chen
Managing partnerFounder & Managing Partner
Eric Huang
PartnerPartner
Lee Cooper
PartnerManaging Director
Tej Pavoor
PartnerPartner
Tim Xiao
PartnerPartner
Agnes Kwok
Platform and operationsFinancial Controller
Andrea Lok
Platform and operationsExecutive Assistant
Ban Ling Kwok
Platform and operationsCco & Financialcontroller Of Delos Advisors, Inc. · since Nov 1, 2023
Carrie Greenaway
Platform and operationsOffice Manager
Eric Huang
Platform and operationsVice Treasurer Of Delos Advisors, Inc. · since Nov 1, 2023
Paul Shen
Platform and operationsOperations Manager
Wynne Chan
Platform and operationsOffice Manager
Investments on record
11 edges, 11 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
7 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
1 dated events
- Mar 14, 2025Delos Advisors, Inc. appears on the SEC adviser roster (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Classification history
- Sep 12, 2026Institutional venture firm (probable, 70%, cls-1)venture manager with no reported fund assets yet (scale unknown)
Evidence
30 observations from 3 sources
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|---|---|---|---|
| Why admitted | vc_exemption | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| SEC exemption claimed | venture_capital_fund_adviser | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| SEC adviser type | exempt_reporting_adviser | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Latest Form ADV filing | 2026-02-27 | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Adv pdf loaded | adv-pdf-1 | Sep 12, 2026 | Fact | IAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A) |
| SEC status | ERA - Active | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| SEC status effective | 2025-03-14 | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Business phone | 617-634-3450 | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Contact page url | https://www.deloscapital.com/wp-content/plugins/contact-form-7/includes/css/styles.css “contact page linked from the home page” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Description | Delos Capital invests in life science, biotech, and medtech companies transforming bold ideas into medical breakthroughs. “meta description” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Description | Delos Capital invests in life science, biotech, and medtech companies transforming bold ideas into medical breakthroughs. “meta description” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Headquarters | Cambridge, MA | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Office address | 201 BROADWAY, SUITE 330, Cambridge, MA, 02139 | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Self-described type | venture_capital “Biotech Venture Capital Firm | Delos Capital” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Self-described type | venture_capital “Biotech Venture Capital Firm | Delos Capital” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Legal form | Corporation | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Portfolio page | https://www.deloscapital.com/portfolio/ “11 entries read” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Portfolio page | https://www.deloscapital.com/portfolio/ “11 entries read” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Private funds reported | 0 | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Private fund gross assets (reported) | $0 | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Stated geography | global “geography words on the home page” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated geography | global “geography words on the home page” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated sectors | biotech “sector words on the home page” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated sectors | biotech “sector words on the home page” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Team page | https://www.deloscapital.com/team/ “11 name/title pairs read” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Team page | https://www.deloscapital.com/team/ “11 name/title pairs read” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Venture funds reported | 0 | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Website | https://www.deloscapital.com/delos | Feb 27, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Site title | Biotech Venture Capital Firm | Delos Capital “title tag” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Site title | Biotech Venture Capital Firm | Delos Capital “title tag” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |